Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2224]

Essential breast cancer medicines

Dr Didier Verhoeven, Prof Helena Earl, Prof Ahmed Magdy and Prof Luiz Gebrim

Essential breast cancer medicines ( Dr Didier Verhoeven, Prof Helena Earl, Prof Ahmed Magdy and Prof Luiz Gebrim )

Empowering cancer care in Africa

Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo...

Empowering cancer care in Africa ( Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo, Mozambique and AORTIC President )

Principles and practice of prognostication

Dr Martin Stockler Sydney University, Sydney, Australia

Principles and practice of prognostication ( Dr Martin Stockler Sydney University, Sydney, Australia )

Avoiding burnout

Dr Susannah Stanway - UKI Global Cancer Network, London, UK

Avoiding burnout ( Dr Susannah Stanway - UKI Global Cancer Network, London, UK )

Health and Peace

Dr Susannah Stanway - UKI Global Cancer Network, London, UK

Health and Peace ( Dr Susannah Stanway - UKI Global Cancer Network, London, UK )

Common Sense Oncology: Socialist vs Capitalist Oncology

Dr Shailesh Shrikhande - Tata Medical Center, Mumbai, India

Common Sense Oncology: Socialist vs Capitalist Oncology ( Dr Shailesh Shrikhande - Tata Medical Center, Mumbai, India )

Cancer control in India - Role of cancer registries

Dr Prashant Mathur - ICMR-National Center for Disease Informatics and Research...

Cancer control in India - Role of cancer registries ( Dr Prashant Mathur - ICMR-National Center for Disease Informatics and Research, Bengaluru, India )

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers

Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers ( Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU )

Tarlatamab for SCLC: Subgroup analysis shows benefit regardless of previous...

Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain

Tarlatamab for SCLC: Subgroup analysis shows benefit regardless of previous chemo or anti-PD-(L)1 use ( Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain )

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

Best practice in precision medicine for prostate cancer

Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich

Best practice in precision medicine for prostate cancer ( Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich )

ESMO 2025: Latest in EGFR mutant NSCLC

Dr Alfredo Addeo, Prof Nicolas Girard, Dr Anna Minchom and Prof Pascale Tomasini

ESMO 2025: Latest in EGFR mutant NSCLC ( Dr Alfredo Addeo, Prof Nicolas Girard, Dr Anna Minchom and Prof Pascale Tomasini )

More from ecancer